Anthony Harrington
Anthony is a Partner at Alantra with over 15 years of M&A experience in the healthcare sector. He is recognised as one of the leading advisors in the pharma services sector. Anthony has worked on more than 40 M&A transactions and a variety of strategic advisory projects for a range of clients in the UK, US, Europe and Asia. Prior to joining Alantra, Anthony held positions in the healthcare teams at Bear Sterns and Rothschild. He has advised high-profile pharma services business including Cherry Healthcare on its sale to Avenir Global, Prescient Healthcare Group on the investment from Baird Capital, …
Anthony is a Partner at Alantra with over 15 years of M&A experience in the healthcare sector.
He is recognised as one of the leading advisors in the pharma services sector. Anthony has worked on more than 40 M&A transactions and a variety of strategic advisory projects for a range of clients in the UK, US, Europe and Asia.
Prior to joining Alantra, Anthony held positions in the healthcare teams at Bear Sterns and Rothschild. He has advised high-profile pharma services business including Cherry Healthcare on its sale to Avenir Global, Prescient Healthcare Group on the investment from Baird Capital, Lucid Group on the investment from LDC, STEM on its £84m sale to UDG plc and Hive on its £50m sale to St Ives plc. Anthony also sits on the awards judging panel for healthcare industry body Communiqué.
Away from work, Anthony is a keen rugby player.
See more
He is recognised as one of the leading advisors in the pharma services sector. Anthony has worked on more than 40 M&A transactions and a variety of strategic advisory projects for a range of clients in the UK, US, Europe and Asia.
Prior to joining Alantra, Anthony held positions in the healthcare teams at Bear Sterns and Rothschild. He has advised high-profile pharma services business including Cherry Healthcare on its sale to Avenir Global, Prescient Healthcare Group on the investment from Baird Capital, Lucid Group on the investment from LDC, STEM on its £84m sale to UDG plc and Hive on its £50m sale to St Ives plc. Anthony also sits on the awards judging panel for healthcare industry body Communiqué.
Away from work, Anthony is a keen rugby player.
Articles: Anthony Harrington
Private Equity Targeting Healthcare & Consulting Comms Companies
Opinion / Anthony Harrington of global investment banking and asset management firm Alantra outlines why healthcare and consulting communications companies are increasingly attractive targets for private equity. The supply of PE money chasing fewer and fewer assets is only going to increase the attraction of healthcare communications and consulting firms to PE investors Healthcare communications and…
Latest Report
